Treanda Dosage

An Introduction to Dosing With Treanda

The dose of Treanda^® (bendamustine) your healthcare provider recommends will vary, based on a number of factors, including:

 

 

As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.

 

Treanda Dosage for Chronic Lymphocytic Leukemia

The recommended Treanda dose for the treatment of chronic lymphocytic leukemia (CLL) is based on body surface area, which is normally calculated using height and weight. Dosing based on body surface area is expressed as milligrams per meters squared (mg per m²).

 

Specifically, the recommended dose is 100 mg per m² given intravenously (by IV) over 30 minutes. This dose is given once a day for two days in a row every 28 days. This 28-day period is called a treatment cycle. Treanda is given on days one and two of the cycle, followed by 26 days without treatment. The cycle may then be repeated up to six times.

 

Your healthcare provider may reduce your amount or recommend a longer break between doses if you experience potentially serious Treanda side effects, such as low blood cell counts. For example, some people with CLL may be given doses as low as 25 mg per m².